menu

TAG: CERES NANO

Wastewater Testing Labs Can Automate Sample Processing for High Throughput With All-In-One Kit

New purification system launched by Promega includes Ceres Nanosciences’ Nanotrap® particles for virus concentration MADISON, Wis.–(BUSINESS WIRE)–Wastewater testing labs can now scale up their infectious disease surveillance using two reliable technologies in a single kit. The new system released by Promega Corporation pairs the company’s Maxwell® HT chemistry with Ceres Nanosciences’ Nanotrap® particles, an established technology for capturing and concentrating low-abundance analytes such as viral particles. Together, these technologies empower labs to purify pathogen nucleic acids from wastewater samples in high-throughput workflows. “Ceres has a technology that enables concentration of microbes from wastewater that is unique to the market”Tweet this “Ceres has a...

READ MORE
Ceres Nanosciences Receives $1.4M From NIH RADx Initiative to Add Five Additional Wastewater-Based Epidemiology Centers of Excellence

Manassas, Virginia – December 2, 2022 Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing today that it is expanding the network of wastewater-based epidemiology centers of excellence that was established with support from the National Institutes of Health (NIH) RADx® initiative. With a new $1.4 million award from the NIH, Ceres will identify and establish five additional centers of excellence to join the existing network of 16 sites comprising public health labs, non-profit labs, university labs, and commercial testing labs in 14 states. Ceres also will support the verification of...

READ MORE
Streck Announces Series B Investment in Ceres Nanosciences

La Vista, Nebraska – September 14, 2022 Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment will be used to accelerate the development and commercialization of both diagnostic and research use products utilizing Ceres’ Nanotrap® technology platform. “Streck has a deep presence in and knowledge of the diagnostics industry and shares our commitment to building long-term relationships with partners and customers,” said Ceres CEO Ross Dunlap. “We are thrilled to have Streck’s support and guidance in this next, exciting phase of our growth.” This investment builds on the pre-existing partnership between Ceres and Streck,...

READ MORE
Streck establishes partnership with Ceres Nanosciences to distribute COVID-19 wastewater surveillance solution

La Vista, NE – January 10, 2022 Streck today announced a partnership with Ceres Nanosciences to distribute Nanotrap® Magnetic Virus Particles that provide rapid viral concentration directly from raw sewage. This product dramatically reduces the time and effort required to test wastewater samples for COVID-19 surveillance. Wastewater surveillance can act as an early-warning system for COVID-19 “hotspots” within a community. The Ceres Nanotrap Magnetic Virus Particles facilitate a streamlined workflow, improved sensitivity, and reduced time to results. Nanotrap Magnetic Virus Particles are For Research Use Only. Not for use in diagnostic procedures. Traditional methods for concentration of virus from wastewater are...

READ MORE
Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative

MANASSAS, Virginia – November 9, 2021 Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine new wastewater-based epidemiology centers of excellence, as part of the April 2021 $8.2 million award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. Wastewater-based epidemiology can help communities monitor infection dynamics for SARS-CoV-2 and can serve as an early-warning system for the virus in a population, but widespread implementation has been stymied by lack of robust, high-throughput viral concentration methods.​ Ceres’ Nanotrap® Magnetic Virus Particles address...

READ MORE
NIH Awards Ceres Nanosciences $8.2M for Wastewater-Based COVID-19 Surveillance

Apr 21, 2021 GenomeWeb NEW YORK – Ceres Nanosciences announced on Wednesday it has been awarded an $8.2 million contract from the National Institutes of Health’s Rapid Acceleration of Diagnostics Initiative. The funding will support the development and implementation of wastewater-based surveillance systems for COVID-19. Manassas, Virginia-based Ceres plans to develop surveillance systems using its Nanotrap particle technology at a network of sites, with an emphasis on underserved and vulnerable populations. In a statement, Ceres noted that wastewater surveillance can be used to monitor trends in SARS-CoV-2 infection at a population level, but that “widespread implementation has been stymied by...

READ MORE
1 2 3 4
GreyBird Ventures

is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.

MEET THE PEOPLE

For additional information, please contact: greybird@greybirdventures.com

DISCLAIMER